PHILADELPHIA and DUBLIN, Ireland, February 9 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, will announce full year 2008 earnings on Thursday 19 February 2009.
Results press release will be issued at: 12:00 GMT / 07:00 EST Investor meeting and conference call time: 14:00 GMT / 09:00 EST
Investor & Analyst meeting and conference call:
Angus Russell, Chief Executive Officer, Graham Hetherington, Chief Financial Officer, Mike Cola, President, Specialty Pharmaceuticals and Sylvie Gregoire, President, Human Genetic Therapies will host the investor and analyst meeting and conference call at 14:00 GMT/9:00 EST.
The meeting will take place at the offices of Deutsche Bank, Winchester House, 1 Great Winchester Street, London, EC2N 2DB.
Please email firstname.lastname@example.org to register to attend this meeting in London.
The details of the conference call are as follows: UK and International dial in +44(0)20-7806-1957 US dial in: +1-718-354-1388 Password/Conf ID: 9465839 Live Webcast:
A replay of the presentation will be available for two weeks by phone and by webcast for one year. Details are as follows:
UK and International dial in: +44(0)20-7806-1970 US dial in +1-718-354-1112 Pin code 9465839# Webcast replay:
Notes to editors
Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit hyperactivity disorder (ADHD), human genetic therapies (HGT) and gastrointestinal (GI) diseases as well as opportunities in other therapeutic areas to the extent they arise through acquisitions. Shire's in-licensing, merger and acquisition efforts are focused on products in specialist markets with strong intellectual property protection and global rights. Shire believes that a carefully selected and balanced portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.
For further information on Shire, please visit the Company's website: http://www.shire.com
|SOURCE Shire Plc|
Copyright©2009 PR Newswire.
All rights reserved